Healthcare provider profile · identity verified

Christopher Charles Wagner, DO

Family Practice · SHELBY, MI · NPI 1982134482

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	564	158
Lisinopril	Lisinopril	365	109
Omeprazole	Omeprazole	262	73
Amlodipine Besylate	Amlodipine Besylate	228	63
Levothyroxine Sodium	Levothyroxine Sodium	219	48
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	185	52
Metoprolol Succinate	Metoprolol Succinate	184	53
Albuterol Sulfate Hfa	Albuterol Sulfate	174	71
Tamsulosin Hcl	Tamsulosin Hcl	174	56
Gabapentin	Gabapentin	173	53
Losartan Potassium	Losartan Potassium	164	45
Rosuvastatin Calcium	Rosuvastatin Calcium	150	47
Metformin Hcl	Metformin Hcl	148	40
Duloxetine Hcl	Duloxetine Hcl	141	35
Eliquis	Apixaban	134	29
Furosemide	Furosemide	112	42
Hydrochlorothiazide	Hydrochlorothiazide	108	35
Pravastatin Sodium	Pravastatin Sodium	107	25
Simvastatin	Simvastatin	106	26
Carvedilol	Carvedilol	99	34
Fluticasone Propionate	Fluticasone Propionate	99	39
Pantoprazole Sodium	Pantoprazole Sodium	92	33
Citalopram Hbr	Citalopram Hydrobromide	82	26
Prednisone	Prednisone	79	57
Pregabalin	Pregabalin	66	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	35
Famotidine	Famotidine	61	19
Trazodone Hcl	Trazodone Hcl	59	20
Mounjaro	Tirzepatide	58	14
Sertraline Hcl	Sertraline Hcl	58	24
Finasteride	Finasteride	57	21
Baclofen	Baclofen	56	22
Buspirone Hcl	Buspirone Hcl	56	19
Metoprolol Tartrate	Metoprolol Tartrate	54	17
Alendronate Sodium	Alendronate Sodium	53	12
Warfarin Sodium	Warfarin Sodium	53	11
Montelukast Sodium	Montelukast Sodium	52	16
Atenolol	Atenolol	50	15
Clopidogrel	Clopidogrel Bisulfate	50	16
Hydroxyzine Hcl	Hydroxyzine Hcl	50	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	50	11
Ezetimibe	Ezetimibe	49	18
Tramadol Hcl	Tramadol Hcl	48	20
Azithromycin	Azithromycin	47	39
Spironolactone	Spironolactone	47	16
Glipizide Er	Glipizide	43	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	18
Allopurinol	Allopurinol	42	13
Amitriptyline Hcl	Amitriptyline Hcl	41	15
Jardiance	Empagliflozin	40	suppressed
Ventolin Hfa	Albuterol Sulfate	40	13
Trulicity	Dulaglutide	37	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	36	11
Aripiprazole	Aripiprazole	35	suppressed
Glipizide	Glipizide	35	suppressed
Celecoxib	Celecoxib	34	13
Doxazosin Mesylate	Doxazosin Mesylate	34	suppressed
Ibuprofen	Ibuprofen	34	14
Bumetanide	Bumetanide	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	15
Farxiga	Dapagliflozin Propanediol	33	suppressed
Lorazepam	Lorazepam	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	12
Entresto	Sacubitril/Valsartan	32	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	30	26
Metformin Hcl Er	Metformin Hcl	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Cephalexin	Cephalexin	27	20
Methylphenidate Er	Methylphenidate Hcl	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	25	17
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Dilantin	Phenytoin Sodium Extended	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Meloxicam	Meloxicam	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	16
Xarelto	Rivaroxaban	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	22	suppressed
Tradjenta	Linagliptin	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	18	suppressed
Azelastine Hcl	Azelastine Hcl	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Ozempic	Semaglutide	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Januvia	Sitagliptin Phosphate	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	13	suppressed
Sulfasalazine	Sulfasalazine	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Carbamazepine Er	Carbamazepine	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Bydureon Bcise	Exenatide Microspheres	11	suppressed
Digoxin	Digoxin	11	suppressed
Estradiol	Estradiol	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Ubrelvy	Ubrogepant	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error